Diagnostic Technologies

USPSTF proposes new cervical cancer screening guidelines

By Liz Carey

While some signals abroad favor HPV DNA testing, USPSTF stays focused on cervical cytology alone or in combination.

December 11, 2024

Biomemory raises $18M in series A funding

By LabPulse.com staff writers

DNA data storage firm Biomemory announced that it has raised $18 million in series A funding.

December 10, 2024

BioMérieux's Biofire tropical fever panel gets special 510(k) clearance

By LabPulse.com staff writers

The U.S. Food and Drug Administration (FDA) has granted special 510(k) clearance to BioMérieux's syndromic tropical fever panel, developed in conjunction with U.S. government agencies.

December 9, 2024

Nationwide claims analysis questions value of multiplex molecular panels for UTI

By Liz Carey

Reimbursement for molecular syndromic panel testing for UTI may continue to face uncertainty.

December 10, 2024

VA to offer no-cost pharmacogenomic testing program

By LabPulse.com staff writers

The U.S. Department of Veterans Affairs (VA) is offering no-cost pharmacogenomic testing to veterans enrolled at Veterans Integrated Service Network 4 facilities through the end of 2025.

December 5, 2024

GeneDx expands exome testing program for pediatric epilepsy patients

By LabPulse.com staff writers

GeneDx has expanded its patient access program for pediatric epilepsy, which provides access to whole exome sequencing to qualifying pediatric patients.

December 5, 2024

Oncocyte releases data on transplant rejection assay

By LabPulse.com staff writers

Diagnostics developer Oncocyte has announced study data showing that its monitoring assay for kidney transplant rejection significantly reduces the time to diagnosis.

December 4, 2024

Devyser gets IVDR approval for fetal RHD test

By LabPulse.com staff writers

Devyser Diagnostics has received In Vitro Diagnostic Regulation (IVDR) certification for its noninvasive fetal rhesus D (RHD) screening test.

December 2, 2024

OraSure awarded BARDA contract for Marburg virus disease test

By LabPulse.com staff writers

OraSure Technologies was awarded federal funding for the development of a Marburg virus disease rapid antigen test.

December 2, 2024

Oxford Nanopore, UK Biobank to collaborate on epigenetic dataset

By LabPulse.com staff writers

Oxford Nanopore and the UK Biobank are collaborating on an initiative to create a comprehensive, large-scale epigenetic dataset, with the aim of gaining critical insights into the mechanisms of common diseases.

November 27, 2024

Cross-contamination in lab testing triggers needless recalls

By LabPulse.com staff writers

Cases raise awareness of the damaging consequences of erroneous microbiology laboratory testing results.

November 27, 2024

Evolutionary medical genomics program launched in Barcelona

By LabPulse.com staff writers

Three Barcelona, Spain-based research institutions launched the first Joint Program on Evolutionary Medical Genomics last week at an inaugural symposium held at the Barcelona Biomedical Research Park.

November 25, 2024

Page 1 of 323

Next Page